The North America Inhalation and Nasal Spray Generic Drugs Market would witness market growth of 8.0% CAGR during the forecast period (2022-2028).
Inhalation therapy involves dispersing medications into the patient's airways by an aerosol spray, mist, or powder. Although the respiratory system is the main target of inhaled drugs, there may also be systemic effects. Most inhaler users have asthma or another chronic respiratory condition, therefore they must learn how to administer their own medication. There are many different types of inhalers available, so it is crucial to carefully check and abide by the manufacturer's instructions to ensure the proper dose.
Nebulization is the process of adding drugs to inhaled air to create a mist that is subsequently absorbed by the patient through the respiratory system. The drug is delivered by a face mask or any mouthpiece held in between the patient's teeth, and the air droplets are smaller than those produced by metered dose inhalers. The main delivery mechanism for drugs used to cure asthma and chronic obstructive lung disease is inhalers. When the patient uses an inhaler properly, the medicine is delivered to their lungs, where it can start controlling any symptoms.
The prevalence of asthma is very high in regional countries. According to the CDC, there were 25,191 thousand Americans who were asthmatic as of 2017. There were 11,462 thousand asthmatics who reported having at least one asthma attack. Moreover, the mortality rate was also very high as 3,564 people in the nation passed away from asthma-related causes. Since there were 3,615 deaths attributed to asthma in 2015, the death rate increased. 219 of those fatalities were in people under the age of 18.
The US market acquired maximum revenue share in the North America Inhalation And Nasal Spray Generic Drugs Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $7,615.2 million by 2028. The Canada market is poised to grow at a CAGR of 10.4% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 9.4% during (2022 - 2028).
Based on End-user, the market is segmented into Homecare, Hospitals, and Others. Based on Drugs Class, the market is segmented into Bronchodilators, Combination Drugs, Antihistamines, Corticosteroids, Decongestant Sprays, and Others. Based on Indication, the market is segmented into Asthma, Chronic Obstructive Pulmonary Disease (COPD), Allergic Rhinitis, and Others. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospitals Pharmacy, and Online Pharmacies. Based on Demographics, the market is segmented into Adult Patient, Geriatric Patient, and Pediatric Patient. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Inhalation and Nasal Spray Generic Drugs Market is Estimated to reach $29.9 Billion by 2028, at a CAGR of 8.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Viatris, Inc., Akorn, Operating Company LLC, Cipla Limited, Teva Pharmaceuticals Industries Ltd., Novartis AG (Sandoz International GmBH), Apotex, Inc., Hikma Pharmaceuticals PLC, Sun Pharmaceuticals Industries Ltd., Beximco Pharmaceuticals Ltd.
Scope of the Study
Market Segments Covered in the Report:
By End-user
By Drugs Class
- Bronchodilators
- Combination Drugs
- Antihistamines
- Corticosteroids
- Decongestant Sprays
- Others
By Indication
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Allergic Rhinitis
- Others
By Distribution Channel
- Retail Pharmacy
- Hospitals Pharmacy
- Online Pharmacies
By Demographics
- Adult Patient
- Geriatric Patient
- Pediatric Patient
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Viatris, Inc.
- Akorn, Operating Company LLC
- Cipla Limited
- Teva Pharmaceuticals Industries Ltd.
- Novartis AG (Sandoz International GmBH)
- Apotex, Inc.
- Hikma Pharmaceuticals PLC
- Sun Pharmaceuticals Industries Ltd.
- Beximco Pharmaceuticals Ltd.
TABLE 1 North America Inhalation And Nasal Spray Generic Drugs Market, 2018 - 2021, USD Million
TABLE 2 North America Inhalation And Nasal Spray Generic Drugs Market, 2022 - 2028, USD Million
TABLE 3 North America Inhalation And Nasal Spray Generic Drugs Market by End-user, 2018 - 2021, USD Million
TABLE 4 North America Inhalation And Nasal Spray Generic Drugs Market by End-user, 2022 - 2028, USD Million
TABLE 5 North America Homecare Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Homecare Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Inhalation And Nasal Spray Generic Drugs Market by Drugs Class, 2018 - 2021, USD Million
TABLE 12 North America Inhalation And Nasal Spray Generic Drugs Market by Drugs Class, 2022 - 2028, USD Million
TABLE 13 North America Bronchodilators Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Bronchodilators Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Combination Drugs Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Combination Drugs Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Antihistamines Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Antihistamines Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Corticosteroids Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Corticosteroids Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Decongestant Sprays Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Decongestant Sprays Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Inhalation And Nasal Spray Generic Drugs Market by Indication, 2018 - 2021, USD Million
TABLE 26 North America Inhalation And Nasal Spray Generic Drugs Market by Indication, 2022 - 2028, USD Million
TABLE 27 North America Asthma Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Asthma Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Chronic Obstructive Pulmonary Disease (COPD) Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Chronic Obstructive Pulmonary Disease (COPD) Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Allergic Rhinitis Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Allergic Rhinitis Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Inhalation And Nasal Spray Generic Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 36 North America Inhalation And Nasal Spray Generic Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 37 North America Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Hospitals Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Hospitals Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Online Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Online Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Inhalation And Nasal Spray Generic Drugs Market by Demographics, 2018 - 2021, USD Million
TABLE 44 North America Inhalation And Nasal Spray Generic Drugs Market by Demographics, 2022 - 2028, USD Million
TABLE 45 North America Adult Patient Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Adult Patient Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Geriatric Patient Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Geriatric Patient Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Pediatric Patient Market by Country, 2018 - 2021, USD Million
TABLE 50 North America Pediatric Patient Market by Country, 2022 - 2028, USD Million
TABLE 51 North America Inhalation And Nasal Spray Generic Drugs Market by Country, 2018 - 2021, USD Million
TABLE 52 North America Inhalation And Nasal Spray Generic Drugs Market by Country, 2022 - 2028, USD Million
TABLE 53 US Inhalation And Nasal Spray Generic Drugs Market, 2018 - 2021, USD Million
TABLE 54 US Inhalation And Nasal Spray Generic Drugs Market, 2022 - 2028, USD Million
TABLE 55 US Inhalation And Nasal Spray Generic Drugs Market by End-user, 2018 - 2021, USD Million
TABLE 56 US Inhalation And Nasal Spray Generic Drugs Market by End-user, 2022 - 2028, USD Million
TABLE 57 US Inhalation And Nasal Spray Generic Drugs Market by Drugs Class, 2018 - 2021, USD Million
TABLE 58 US Inhalation And Nasal Spray Generic Drugs Market by Drugs Class, 2022 - 2028, USD Million
TABLE 59 US Inhalation And Nasal Spray Generic Drugs Market by Indication, 2018 - 2021, USD Million
TABLE 60 US Inhalation And Nasal Spray Generic Drugs Market by Indication, 2022 - 2028, USD Million
TABLE 61 US Inhalation And Nasal Spray Generic Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 62 US Inhalation And Nasal Spray Generic Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 63 US Inhalation And Nasal Spray Generic Drugs Market by Demographics, 2018 - 2021, USD Million
TABLE 64 US Inhalation And Nasal Spray Generic Drugs Market by Demographics, 2022 - 2028, USD Million
TABLE 65 Canada Inhalation And Nasal Spray Generic Drugs Market, 2018 - 2021, USD Million
TABLE 66 Canada Inhalation And Nasal Spray Generic Drugs Market, 2022 - 2028, USD Million
TABLE 67 Canada Inhalation And Nasal Spray Generic Drugs Market by End-user, 2018 - 2021, USD Million
TABLE 68 Canada Inhalation And Nasal Spray Generic Drugs Market by End-user, 2022 - 2028, USD Million
TABLE 69 Canada Inhalation And Nasal Spray Generic Drugs Market by Drugs Class, 2018 - 2021, USD Million
TABLE 70 Canada Inhalation And Nasal Spray Generic Drugs Market by Drugs Class, 2022 - 2028, USD Million
TABLE 71 Canada Inhalation And Nasal Spray Generic Drugs Market by Indication, 2018 - 2021, USD Million
TABLE 72 Canada Inhalation And Nasal Spray Generic Drugs Market by Indication, 2022 - 2028, USD Million
TABLE 73 Canada Inhalation And Nasal Spray Generic Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 74 Canada Inhalation And Nasal Spray Generic Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 75 Canada Inhalation And Nasal Spray Generic Drugs Market by Demographics, 2018 - 2021, USD Million
TABLE 76 Canada Inhalation And Nasal Spray Generic Drugs Market by Demographics, 2022 - 2028, USD Million
TABLE 77 Mexico Inhalation And Nasal Spray Generic Drugs Market, 2018 - 2021, USD Million
TABLE 78 Mexico Inhalation And Nasal Spray Generic Drugs Market, 2022 - 2028, USD Million
TABLE 79 Mexico Inhalation And Nasal Spray Generic Drugs Market by End-user, 2018 - 2021, USD Million
TABLE 80 Mexico Inhalation And Nasal Spray Generic Drugs Market by End-user, 2022 - 2028, USD Million
TABLE 81 Mexico Inhalation And Nasal Spray Generic Drugs Market by Drugs Class, 2018 - 2021, USD Million
TABLE 82 Mexico Inhalation And Nasal Spray Generic Drugs Market by Drugs Class, 2022 - 2028, USD Million
TABLE 83 Mexico Inhalation And Nasal Spray Generic Drugs Market by Indication, 2018 - 2021, USD Million
TABLE 84 Mexico Inhalation And Nasal Spray Generic Drugs Market by Indication, 2022 - 2028, USD Million
TABLE 85 Mexico Inhalation And Nasal Spray Generic Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 86 Mexico Inhalation And Nasal Spray Generic Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 87 Mexico Inhalation And Nasal Spray Generic Drugs Market by Demographics, 2018 - 2021, USD Million
TABLE 88 Mexico Inhalation And Nasal Spray Generic Drugs Market by Demographics, 2022 - 2028, USD Million
TABLE 89 Rest of North America Inhalation And Nasal Spray Generic Drugs Market, 2018 - 2021, USD Million
TABLE 90 Rest of North America Inhalation And Nasal Spray Generic Drugs Market, 2022 - 2028, USD Million
TABLE 91 Rest of North America Inhalation And Nasal Spray Generic Drugs Market by End-user, 2018 - 2021, USD Million
TABLE 92 Rest of North America Inhalation And Nasal Spray Generic Drugs Market by End-user, 2022 - 2028, USD Million
TABLE 93 Rest of North America Inhalation And Nasal Spray Generic Drugs Market by Drugs Class, 2018 - 2021, USD Million
TABLE 94 Rest of North America Inhalation And Nasal Spray Generic Drugs Market by Drugs Class, 2022 - 2028, USD Million
TABLE 95 Rest of North America Inhalation And Nasal Spray Generic Drugs Market by Indication, 2018 - 2021, USD Million
TABLE 96 Rest of North America Inhalation And Nasal Spray Generic Drugs Market by Indication, 2022 - 2028, USD Million
TABLE 97 Rest of North America Inhalation And Nasal Spray Generic Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 98 Rest of North America Inhalation And Nasal Spray Generic Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 99 Rest of North America Inhalation And Nasal Spray Generic Drugs Market by Demographics, 2018 - 2021, USD Million
TABLE 100 Rest of North America Inhalation And Nasal Spray Generic Drugs Market by Demographics, 2022 - 2028, USD Million
TABLE 101 key information – Viatris, Inc.
TABLE 102 Key information - Akorn Operating Company LLC
TABLE 103 Key Information – Cipla Limited
TABLE 104 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 105 Key Information – Novartis AG
TABLE 106 Key Information – Apotex, Inc.
TABLE 107 Key Information – Hikma Pharmaceuticals PLC
TABLE 108 Key Information – Sun Pharmaceuticals Industries Ltd.
TABLE 109 Key Information – Beximco Pharmaceuticals Ltd.
List of Figures
FIG 1 Methodology for the research